It is now well known that the prevalence of diabetes has increased over the last few decades and is predicted to continue to increase. This is not just due to the ageing of populations.
Is Screening and Treatment of Benefit to the Individual?

The ADDITION Study Results
There is a general belief that diagnosing diabetes earlier and subsequent earlier treatment is beneficial. This has been challenged by the investigators of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care (ADDITION) study, an Anglo-Danish-Dutch general practice study of intensive treatment and complication prevention in patients with type 2 diabetes who have been identified by screening. 4 The study aimed to evaluate: whether screening for prevalent undiagnosed type 2 diabetes is feasible, whether subsequent optimised intensive treatment of the disease and associated risk factors is feasible and whether such optimised intervention is beneficial.
The first results of this five-year trial were presented at the European Association for the Study of Diabetes meeting in September 2010, and there are reports available on the Internet. 5, 6 As yet, there are no published reports by the investigators on the results presented at this meeting. Over 70,000 people were screened for diabetes using the first step in the screening process:
the completion of a risk questionnaire, which differed between the recruitment centres. For those deemed to be at risk of having diabetes based on their score on this risk questionnaire, capillary glucose testing and/or evaluation of fasting and/or two-hour plasma glucose with an oral glucose tolerance test were carried out. People screened as positive for diabetes were re-tested. The trial recruited 3,000 newly diagnosed patients with diabetes, who were allocated to one of two treatment arms: intensive or routine care. General practices were randomised into these two treatment arms. After five years of follow-up, the various cardiometabolic risk factors were better controlled in the intensive treatment group, but while the improvements were statistically significant, they were modest. Thus, the protocol of intensive treatment was feasible. However, there
were no statistically significant differences in outcomes: cardiovascular events were reduced by 17% and cardiovascular deaths by 12% in the intensive care group compared with the routine care group. The Kaplan-Meier morbidity curves started to separate at 3.5 years; perhaps a longer follow-up would be necessary to have more events and a higher power to detect differences. It is probable that improvements in the routine care of
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Beverley Balkau  1 and Lei Chen   2 patients with diabetes and the control of obesity and other risk factors resulted in similar levels of risk factors at follow-up in the intensive and the routine care groups. Thus, this trial showed that both screening and intervention were feasible, but the intervention was marginally beneficial for cardiovascular disease. patients and an average follow-up of 4.4 years showed that major cardiovascular events were modestly reduced, with no one trial reaching statistical significance (see Table 1 ).
Reviews of Screening for and Treating Diabetes
The above-mentioned systematic review 7 included 12 studies of intensive glucose control and concluded that glucose lowering was cost-effective in those under 54 years of age, but for older patients it was not cost-effective.
Risk Scores for Diabetes Using Clinical Risk Factors
Risk scores can be used for two purposes: to pre-screen those who may already have diabetes, so they can be sent for a blood test; and to screen those who have a high chance of developing diabetes in the future and who may be targeted for intervention programmes for the prevention of diabetes. The scores can be used in the general population or in a population pre-selected to be at risk of diabetes owing to, for example, their age, adiposity, hypertension or other risk factors. Often, the scores developed in cross-sectional studies or in prospective studies are used for both screening and prediction, and they seem to perform equally well for both purposes. [12] [13] [14] [15] All of the risk scores have been developed in epidemiological studies where diabetes was defined by known diabetes, by fasting glucose or by glucose at fasting and two hours after an oral glucose tolerance test. A limitation with all studies is that they are based on just one blood sample, rather than the two required by the diagnostic criteria for diabetes.
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Diabetes Risk Scores for Screening for Diabetes Many other scores were subsequently created. In the ADDITION study described above, 4 diabetes risk factor questionnaires were used that had been developed from cross-sectional studies in Dutch, English and Danish populations.
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Diabetes Prevention 12 This score was based on data from a registry of diabetes treatment, and was for 10-year incident diabetes. This questionnaire is used either in its original version (see Figure 2 ) or in various adaptations in other countries to select individuals for diabetes prevention programmes. 22, 23 There are now many risk scores for predicting diabetes. [12] [13] [14] [15] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] They are usually developed from logistic regression or Cox proportional hazard models, and include factors that remain significant in multivariate prediction models. Table 2 lists the factors that have been included in such risk models. As might be expected, the factors that appear often are age, gender, family history of diabetes, smoking, blood pressure and body mass index (BMI) or waist circumference.
The question of whether glucose measurements should be added to these scores before initiating prevention programmes was studied by Chen in the Australian AusDiab study. 35 The conclusion was that the initial screening should be by questionnaire, with a second risk score evaluation, including fasting glucose, being made for those at higher risk based on their score in the first questionnaire.
How Do the Clinical Diabetes Risk Scores Perform?
The usual metric used to determine how well a risk score performs is the area under the receiver operating characteristic curve (AROC) of sensitivity and specificity. The closer to one, the better the discrimination between those who will or will not have diabetes in the future (or, in the case of screening for prevalent diabetes, the discrimination between those who have and do not have diabetes).
Different risk scores have been compared on this basis in populations
other than the one in which the risk scores were developed. 36, 37 The sensitivity and specificity and hence the AROC are heavily dependent on the study population, that is whether it is a general population or Diabetes Risk Scores in 2011 a population at high or low risk that has been selected for study. 38 However, it is equally important to take into account the positive predictive value: given the risk score, the probability that an individual will have incident diabetes in the next five or 10 years. This is how the score will be used in practice to predict diabetes. Sensitivity, specificity and also the positive predictive value are dependent on the prevalence of the disease in question and the population selected, so there is no reason to prefer sensitivity and specificity over judging risk scores by the positive predictive value.
38
Biological, Genetic, Proteomic, Lipodomic, Metabolomic, MicroRNA Profiling
Scores with biological markers are not as common as scores with clinical risk markers. One of the earliest was from Stern and was based on the San Antonio Heart Study. 39 There are now a number of published studies with risk scores including routine biological markers, and some of these come from the above publications with clinical risk scores. 14, 24, 25, 28, 29, 31, 32, 34 
Conclusions
Diabetes risk scores have not had the same long history as CVD risk scores, and perhaps scores using clinical factors to predict diabetes will also settle and become more consistent. As these risk scores become better known in the general population, self-identification of the factors associated with a risk of diabetes will become easier; this may help in prevention. These scores could be used by general practitioners, with self-questionnaires available in their waiting rooms. The inclusion of dietary factors and physical activity in these risk scores may be an element for the communication of prevention strategies, even if these factors are statistically not significant.
For diabetes risk scores using blood sampling, glucose and glycated haemoglobin should be provided as part of the results, not just as a statement about the risk of future diabetes. Risk scores should be given with a confidence or an uncertainty interval to better quantify the risk. n
